1. Categorization and association analysis of risk factors for adverse drug events

   • Lina Zhou
   • Anamika Paul Rupa

   Review 08 December 2017 Pages: 389 - 404

   

2. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case–control studies of incidence and associated risk factors

   • Nobuaki Mori
   • Yoshio Kamimura
   • Seiji Bito

   Clinical Trial 08 December 2017 Pages: 405 - 411

3. Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics

   • Kevin J. Freise
   • Beibei Hu
   • Ahmed Hamed Salem

   Clinical Trial 04 January 2018 Pages: 413 - 421

   

4. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China

   • Zhixiong Zhong
   • Jingyuan Hou
   • Pingsen Zhao

   Pharmacogenetics 14 December 2017 Pages: 423 - 431

   

5. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis

   • Ping Wang
   • Xiao-Qian Lin
   • Gong-Hao He

   Pharmacogenetics 14 December 2017 Pages: 433 - 442

   

6. Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

   • Mirjana Novkovic
   • Dragan Matic
   • Ljiljana Rakicevic

   Pharmacogenetics 19 December 2017 Pages: 443 - 451

7. Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel

   • Mirjana Novkovic
   • Dragan Matic
   • Ljiljana Rakicevic

   Correction 05 February 2018 Pages: 453 - 453

8. In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics

   • Yi Jin
   • Hubert Borell
   • Gian Camenisch

   Pharmacogenetics Open access 22 December 2017 Pages: 455 - 464

   

9. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

   • A. E. C. A. B. Willemsen
   • L. M. Knapen
   • N. P. van Erp

   Pharmacokinetics and Disposition Open access 08 December 2017 Pages: 465 - 471

   

10. Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine

    • Nadège Néant
    • Florence Gattacceca
    • Caroline Solas

    Pharmacokinetics and Disposition 26 January 2018 Pages: 473 - 481

    

11. Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013

    • Eva-Stina Hemmingsson
    • Maria Gustafsson
    • Hugo Lövheim

    Pharmacoepidemiology and Prescription Open access 20 December 2017 Pages: 483 - 488

12. Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study

    • Katarina Dathe
    • Stephanie Padberg
    • Christof Schaefer

    Pharmacoepidemiology and Prescription 07 December 2017 Pages: 489 - 495

    

13. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?

    • Kristian Svendsen
    • Kjell H. Halvorsen
    • Beate Garcia

    Pharmacoepidemiology and Prescription 18 December 2017 Pages: 497 - 504

    

14. Degree of prescriber’s knowledge about variability in biological drugs “innovators” in manufacturing process

    • Lucía Jiménez-Pichardo
    • Rocío Gázquez-Pérez
    • Jesús Francisco Sierra-Sánchez

    Pharmacoepidemiology and Prescription 15 December 2017 Pages: 505 - 511

    

15. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

    • R. A. Charlton
    • V. Bettoli
    • H. Dolk

    Pharmacoepidemiology and Prescription 11 December 2017 Pages: 513 - 520

16. Domperidone prolongs oral to duodenal transit time in video capsule endoscopy

    • Michael Mcfarlane
    • B. Liu
    • C. Nwokolo

    Pharmacoepidemiology and Prescription 08 December 2017 Pages: 521 - 524

17. Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining

    • Camille Morival
    • Richard Westerlynck
    • Pascal Le Corre

    Pharmacoepidemiology and Prescription 18 December 2017 Pages: 525 - 534

    

18. Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma

    • Emelie Wolgast
    • Ann Josefsson
    • Margareta Reis

    Pharmacoepidemiology and Prescription Open access 20 December 2017 Pages: 535 - 539